m), 7.56–7.43 (3H, m), 7.40 (1H, s), 7.31 (1H, s); dC(75 MHz,
TFA-d1) 164.1 (s), 163.0 (s), 152.3 (s), 151.3 (s), 142.2 (s), 140.6
(d), 138.2 (s), 135.8 (d), 135.2 (d), 134.7 (d), 134.3 (d), 133.6 (s),
132.8 (s), 132.0 (d), 130.7 (d), 129.7 (d), 127.4 (d), 126.5 (d), 126.2
(d), 122.7 (s), 99.6 (d); m/z (EI) 422 (M+, 22%), 420 (M+-2, 39),
405 (33), 389 (60), 299 (35), 271 (21), 211 (10), 168 (17), 125 (74),
97 (14), 93 (25), 84 (22), 77 (100), 65 (18), 63 (25), 56 (26), 51 (37).
requires C, 74.2; H, 4.0; N, 13.9%); lmax(DCM)/nm 245 (log e
3.42), 304 (3.52), 315 inf (3.49), 349 inf (3.18), 399 inf (2.80),
463 inf (2.89), 488 (2.58), 517 (3.15), 674 (2.52), 623 inf (2.56);
n
max/cm-1 3065w (Ar CH), 1591m, 1518s, 1493m, 1476m, 1452s,
1310m, 972m, 862m, 847m, 781m; dH(300 MHz, TFA-d1) 7.96
(2H, d, J 8.8), 7.82 (1H, br s), 7.73–7.61 (5H, m), 7.53–7.47 (3H,
m), 7.43–7.32 (2H, m), 7.26–7.20 (2H, m), 6.70 (1H, br s); dC(75
MHz, TFA-d1) 154.1 (s), 153.8 (s), 146.9 (s), 143.9 (s), 143.3 (s),
141.2 (s), 135.7 (d), 135.1 (d), 134.3 (d), 133.6 (s), 132.2 (d), 131.0
(d), 130.8 (d), 128.7 (s), 128.5 (d), 127.9 (d), 125.8 (d), 122.0 (s),
122.0 (d), 115.2 (d), 96.8 (d); m/z (EI) 405 (M++1, 39%), 404 (M+,
100), 196 (25), 77 (23), 51 (11).
4.4. Intramolecular cyclocondensation reactions
4.4.1. 1,3-Diphenyl-1,6-dihydro-[1,2,4]triazino[5,6-b]phenazin-
4-ium 4-methylbenzenesulfonate (12). To a stirred solution of
6-(2-aminophenylamino) - 1,3 - diphenylbenzo[e] - [1,2,4]triazin-
7(1H)-one (9) (150 mg, 0.37 mmol) in EtOH (5 ml), TsOH·H2O
was added (70.0 mg, 0.37 mmol) and the mixture heated at reflux
for 10 min. The volatiles were removed in vacuo and the residue
crystallized to afford the title compound 12 (160.9 mg, 78%) as
blue needles, mp >300 ◦C (from DCM–MeOH, 1 : 2), Rf 0.31
(t-BuOMe); (found: C, 68.8; H, 4.4; N, 12.4. C32H25N5O3S requires
C, 68.7; H, 4.5; N, 12.5%); lmax(DCM)/nm 229 (log e 3.45), 242
inf (3.40), 297 (3.72), 560 (3.43), 620 inf (3.09); nmax/cm-1 3063w
(Ar CH), 1524s, 1504s, 1493m, 1391m, 1333m, 1151s, 1123m,
1030m, 1007s, 872m, 854m, 797m; dH(300 MHz, TFA-d1) NH
exchanged 7.77 (2H, d, J 7.7), 7.65–7.43 (12H, m), 7.39–7.31 (3H,
m), 7.17 (2H, d, J 7.9), 6.46 (1H, s, H-12), 3.00 (3H, s, CH3);
dC(75 MHz, TFA-d1) 151.1 (C O), 146.2 (s), 146.0 (s), 145.3 (s),
144.6 (s), 142.8 (s), 141.1 (s), 138.4 (s), 135.4 (d), 134.4 (d), 133.7
(d), 132.5 (d), 132.2 (d), 131.5 (s), 131.0 (d), 130.9 (d), 129.6 (s),
128.0 (s), 128.0 (d), 127.2 (d), 126.0 (d), 120.6 (d), 119.8 (d), 99.5
(d), 95.5 (d), 21.2 (CH3); m/z (EI) 388 (M++1, 34%), 387 (M+,
100), 310 (7), 296 (7), 283 (13), 128 (9), 77 (16).
4.4.4. 1,3,11-Triphenyl-1,6-dihydro-[1,2,4]triazino[5,6-b]phe-
nazin-11-ium 4-methylbenzenesulfonate (15). To
a
stirred
solution of 6-[2-(N-phenylamino)anilino]-1,3-diphenyl-
benzo[e][1,2,4]triazin-7(1H)-one (10) (54.7 mg, 0.11 mmol)
in EtOH (3 ml), TsOH·H2O (19.5 mg, 0.11 mmol) was added and
the mixture heated at reflux for 15 min. The reaction mixture was
cooled to 0 ◦C and then filtered to give the title compound 15 (69.0
◦
mg, 99%) as blue needles, mp 245–248 C (from EtOH), Rf 0.57
(t-BuOMe); (found: C, 71.0, H, 4.8, N, 10.6. C38H29N5O3S·1/2
EtOH requires C, 71.1; H, 4.9; N, 10.6%); lmax(DCM)/nm 308
(log e 3.77), 320 inf (3.67), 401 (2.61), 534 inf (3.17), 574 (3.50),
620.1 (3.59); lmax(EtOH)/nm 305 (log e 4.11), 428 (3.06), 530
inf (3.50), 569 (3.80), 613 (3.86); nmax/cm-1 3414w (NH), 3061w
(Ar CH), 1514s, 1499m, 1468m, 1393m, 1161m, 1121m, 1034m,
1007m; dH(300 MHz, CDCl3) 13.09 (1H, s, NH), 8.06 (2H, d, J
7.1), 7.86 (2H, d, J 8.0), 7.62 (2H, dd, J 7.5, 7.5), 7.52–7.34 (12H,
m), 7.14 (2H, d, J 7.9), 7.07 (1H, s), 6.75 (1H, dd, J 7.2, 7.2),
6.55 (1H, dd, J 7.5, 7.5), 6.07 (1H, d, J 8.1), 5.31 (1H, s, H-12),
3.71 (1H, q, J 7.0, CH3CH2OH), 2.32 (3H, s, CH3), 1.23 (1.5H,
t, CH3CH2OH); dC(75 MHz; CDCl3) one Ar C missing 159.3 (s),
154.4 (s), 145.4 (s), 144.3 (s), 143.5 (s), 140.3 (s), 139.6 (s), 138.8
(s), 135.8 (s), 133.7 (s), 131.8 (d), 131.5 (d), 130.9 (d), 130.6 (d),
130.4 (s), 130.0 (d), 128.9 (d), 128.6 (d), 128.1 (d), 127.6 (d), 127.5
(d), 126.4 (d), 125.8 (d), 125.2 (d), 118.5 (d), 116.5 (d), 102.9 (d),
92.3 (d), 21.6 (CH3); m/z (EI) 464 (M++1, 33%), 463 (M+, 100),
386 (8), 372 (8), 255 (23), 231 (8), 178 (6), 128 (11), 77 (22).
4.4.2. 1,3-Diphenyl-1,6-dihydro-[1,2,4]triazino[5,6-b]phena-
zine (13). To a stirred solution of 6-(2-aminophenylamino)-
1,3-diphenylbenzo[e][1,2,4]triazin-7(1H)-one (9) (55.3 mg, 0.136
mmol) in EtOH (4 ml), TsOH·H2O was added (26.0 mg, 0.137
mmol) and the mixture heated at reflux for 10 min, then cooled
◦
to ca. 20 C and poured into iced water (20 ml). The precipitate
that formed (44.3 mg) was filtered, dissolved in DCM (20 ml)
and washed with NaOH 10% (15 ml). The organic layer was
dried (Na2SO4), filtered and concentrated in vacuo to give the
title compound 13 (22.8 mg, 43%) as blue needles, mp >300 ◦C
(from PhH); (found: C, 77.4; H, 4.4; N, 18.0. C25H17N5 requires
C, 77.5; H, 4.4; N, 18.1%); lmax(DCM)/nm 253 (log e 3.92), 290
(3.97), 514 (3.60), 612 inf (2.87) nmax/cm-1 1569m, 1516m, 1490m,
1449s, 1332m, 1321m, 890m, 772m, 753m; m/z (EI) 388 (M++1,
4.4.5. 1,3,11-Triphenyl-1H-[1,2,4]triazino[5,6-b]phenazin-11-
ium-6-ide (16). To
a stirred solution of 6-[2-(N-phenyl-
amino)anilino]-1,3-diphenylbenzo[e][1,2,4]triazin-7(1H)-one (10)
(64 mg, 0.12 mmol) in EtOH (3 ml), TsOH·H2O (22.8 mg; 0.12
mmol) was added and the mixture heated at reflux for 20 min.
On cooling to ca. 20 ◦C the reaction mixture was then diluted
(DCM, 30 ml) and washed (10% KOH, 15 ml). The organic
layer was separated, dried (Na2SO4) and evaporated in vacuo. The
residue obtained was triturated (DCM–MeOH 1 : 3) to give the
title compound 16 (55.1 mg; 87%) as blue needles, mp >300 ◦C
(from PhH), Rf 0.30 (t-BuOMe); (found: C, 80.3, H, 4.4, N, 15.0.
C31H21N5 requires C, 80.3; H, 4.6; N, 15.1%); lmax(CCl4)/nm 407
(2.31), 426 (log e 2.40), 480 (2.18), 513 (2.18), 564 inf (2.26), 607
(2.39), 657 (2.37); lmax(PhMe)/nm 307 (log e 2.86), 316 (2.78),
403 (2.33), 426 (2.43), 478 (2.22), 510 (2.23), 556 inf (2.28), 601
(2.43), 650 (2.40); lmax(1,4-dioxane)/nm 307 (log e 3.44), 313 inf
(3.37), 403 inf (2.80), 426 (2.92), 477 (2.63), 508 (2.67), 550 inf
(2.76), 593 (2.98), 643 (2.95); lmax(CHCl3)/nm 306 (log e 3.70),
406 inf (3.02), 427 (3.13), 477 (2.81), 508 (2.80), 550 inf (3.02),
591 (3.29), 637 (3.29); lmax(DCM)/nm 307 (log e 3.97), 404 inf
25%), 387 (M+, 100), 103 (19), 77 (C6H5 , 42), 71 (14), 69 (17), 57
+
(18), 55 (19), 51 (15).
4.4.3. 1,3 - Diphenyl - 1H - [1,2,4]triazino[6,5 - b]phenothiazine
(14). To a solution of 6-(2-aminophenylthio)-1,3-diphenyl-
benzo[e][1,2,4]triazin-7(1H)-one (11) (155.5 mg, 0.37 mmol) in
EtOH (9 ml) TsOH·H2O (72.0 mg, 0.38 mmol) was added and the
mixture was heated at reflux for 20 min then cooled to ca. 20 ◦C
and poured into iced water (20 ml). The precipitate that formed
was filtered, dissolved in DCM (25 ml) and washed with NaOH
10% (20 ml). The organic layer was dried (Na2SO4), filtered and
concentrated in vacuo to give the title compound 14 (121.3 mg,
82%) as green needles, mp 256–260 ◦C (from PhCl), Rf 0.84 (t-
BuOMe–hexane, 3 : 1); (found: C, 74.3; H, 4.1; N, 14.0. C25H16N4S
1346 | Org. Biomol. Chem., 2012, 10, 1339–1348
This journal is
The Royal Society of Chemistry 2012
©